Comparison of carprofen and flunixin meglumine as adjunctive therapy in bovine respiratory disease.

In an open, controlled, multi-centre clinical field trial, seven 'naturally occurring' outbreaks of acute febrile (rectal temperature > or = 39.5 degrees C) respiratory disease in housed calves were treated with a single antimicrobial agent, and either the non-steroidal anti-inflammatory drug (NSAID) carprofen (n = 95) or flunixin meglumine (n = 92) on an alternate basis. Carprofen was administered as a single subcutaneous injection at a mean dosage of 1.4 mg kg-1 (range 1.2 to 1.9 mg kg-1) body weight on the first day and flunixin meglumine by intravenous injection at a mean dosage of 2.0 mg kg-1 (range 1.2 to 2.6 mg kg-1) body weight on the first 3 consecutive days. All calves were examined clinically immediately prior to initial treatment and on three occasions up to 1 week after the end of treatment. There were no statically significant differences between NSAID groups in reduction of clinical parameters between examinations, or in overall efficacy. This trial demonstrated that a single dose of carprofen was equally effective as three daily doses of flunixin meglumine as adjunctive therapy to antimicrobial treatment in acute respiratory disease in calves.

Distribution of Pasteurella haemolytica in the respiratory tracts of carrier calves and those subsequently infected experimentally with Dictyocaulus viviparus.

Distribution of Pasteurella haemolytica in the respiratory tracts of calves with no apparent clinical signs of illness and those infected experimentally with Dictyocaulus viviparus was determined so as to define carrier sites for this organism. The calves had been positive by nasopharyngeal swab for either P haemolytica A2 or A1 for at least two months or for over a month, respectively, before slaughter. P haemolytica A1 was acquired following horizontal spread from other infected calves. It was observed post mortem that P haemolytica A1 or A2 resided in the tonsils and retropharyngeal lymph nodes of calves of both groups. In addition to these sites, P haemolytica A1 was also isolated from the right cranial lung lobe of one of the calves from the D viviparus infected group although there was no evidence of pasteurella associated pneumonia. It was concluded that tonsil and retropharyngeal lymph nodes appear to be the most important carrier sites for P haemolytica when compared to other tissues of the bovine respiratory tract.

Pasteurella species isolated from the bovine respiratory tract and their antimicrobial sensitivity patterns.

Pasteurella haemolytica biotype A, serotype 1 (P haemolytica A1) was the most commonly isolated Pasteurella species from 80 calves examined at necropsy from 40 outbreaks of respiratory disease, the majority of which were pathologically confirmed as bovine pneumonic pasteurellosis (transit fever; shipping fever). Similarly, nasopharyngeal swabs from in-contact and apparently healthy calves indicated the widespread presence of P haemolytica A1. Pasteurella multocida and other serotypes of P haemolytica A1 were found including six isolations of P haemolytica T10, a fairly common pathogen in sheep. Approximately two-thirds of the isolates were tested for their antimicrobial sensitivity patterns and the degree of sensitivity for P haemolytica A1, the most frequently isolated serotype, was chloramphenicol (100 per cent), sulphamethoxazole trimethoprim (98 per cent), oxytetracycline (80 per cent), ampicillin (85 per cent), penicillin (82 per cent), streptomycin (3 per cent) and lincomycin (1 per cent).

Sequential lesions of experimental bovine pneumonic pasteurellosis.

A strain of Pasteurella haemolytica biotype A serotype 1, which had been isolated from a pathologically-confirmed outbreak of bovine pneumonic pasteurellosis, was used successfully to reproduce the disease in conventional calves. The development of the various pathological features was studied at regular intervals following infection. The acute inflammatory reaction which had developed by day 2 after initial infection was characterised by flooding of the alveoli by oedema and neutrophils together with a mild degree of bronchiolar epithelial necrosis. This progressed to an acute exudative fibrinous pneumonia with extensive involvement of the interlobular septa and often with pleurisy. Subsequently, these pulmonary lesions became walled off by fibrous tissue which became infiltrated by plasma cells and lymphocytes. At this stage organisms could be demonstrated only within these nodules in the lung tissue.

Experimental production of infectious bovine keratoconjunctivitis.

The left eyes of 10 conventional dairy cross calves were inoculated with a pathogenic strain of Moraxella bovis and lesions of infectious bovine keratoconjunctivitis developed in nine of these eyes. M bovis was isolated from all inoculated eyes and lesions developed in five out of 10 eyes which had become naturally infected. The clinical and microbiological findings were similar to those described in field cases.

The prevalence of serum precipitating antibody to Aspergillus fumigatus in adult cattle in Britain.

The prevalence of precipitating antibody to A. fumigatus in 3509 sera from adult cattle in 44 herds was 25 per cent. Only 19 per cent of sera from grazing or recently housed animals were positive compared with 30 per cent of those taken towards the end of the winter. Mouldy hay was the most likely source of A. fumigatus antigens although a positive correlation between the prevalence of precipitins and either the mouldiness of the hay or the frequency of coughing in the springtime was not established. However, there was a positive correlation between the age of cattle sampled and the prevalence of antibodies. Mycotic abortion had been confirmed in only one of 6 herds in which more than 80 per cent of the cows were seropositive and so it can be inferred that the presence of serum precipitating antibody is of very little value in the diagnosis of mycotic abortion resulting from A. fumigatus infection.

Experimental production of bovine pneumonic pasteurellosis.

Pneumonic pasteurellosis has been reproduced in conventional, weaned, Friesian-cross calves using a strain of Pasteurella haemolytica biotype A, serotype 1 (P haemolytica A1) isolated from a pathologically confirmed incident of bovine pneumonic pasteurellosis. The major clinical findings were pyrexia, hyperpnoea, tachypnoea, nasal discharge and reduced appetite. Fibrinous pneumonia was present in the lungs of animals at necropsy on days 2 and 3 after initial infection while by days 9 and 10 after initial infection many of the areas of fibrinous pneumonia were confined by a fibrous capsule forming well defined nodules. During the experiment natural transmission of the infecting strain of P haemolytica A1 occurred in two control calves which developed a condition identical to that in the artificially infected calves. P haemolytica A1 was repeatedly recovered from the nasopharynx of infected calves and at necropsy throughout the upper and lower respiratory tracts. Seroconversion, as measured by indirect haemagglutination, to the organism developed in all infected calves by days 9 and 10 after initial infection. The clinical, microbiological and pathological findings were identical to those seen in field incidents of bovine pneumonic pasteurellosis involving recently housed, weaned, single-suckled calves.

Effect of anti-prostaglandin therapy in experimental parainfluenza type 3 pneumonia in weaned, conventional calves.

An acute pneumonia was induced experimentally in 10, 10- to 12-week-old conventional calves by administration into the upper airways of a pathogenic strain of parainfluenza type 3 (PI3) virus. The experimental calves had been selected on the basis of freedom from clinical evidence of respiratory and other diseases, freedom from current infection by PI3 virus as judged by repeated nasopharyngeal swabbing and freedom from earlier PI3 virus infection as judged by their lack of significant levels of serum antibody to that virus. The infection procedure was deemed to have been successful in that infection was established with subsequent seroconversion, clinical signs of a febrile pneumonia arose soon after the administration of virus, histopathological changes characteristic of PI3 pneumonia developed and the presence of PI3 virus antigen was demonstrated by immunofluorescence in association with those lesions. Treatment of five of the pneumonic calves was carried out on days 1, 2 and 3 of the trial using the anti-prostaglandin compound flunixin meglumine and that treatment appeared to be of benefit in that in the test calves there was a prompt cessation of coughing with fewer fevers and lower respiratory rates as compared with the untreated controls. The drug did not appear to influence PI3 infection rates but its administration was associated with a marked reduction in the extent of pulmonary consolidation, probably as the result of its known ability to limit the acute inflammatory response.

A comparison of the virulence of three strains of infectious bovine rhinotracheitis virus.

The virulence of three strains of infectious bovine rhinotracheitis (IBR) virus was compared in six-month-old Ayrshire-cross calves. The strains were an isolate from a recent severe outbreak of IBR in Scotland (Strichen strain), the prototype British strain (Oxford strain) and a North American isolate (Colorado strain). The Colorado and Strichen strains produced the characteristic clinical signs and pathological lesions of severe IBR three to four days post infection (p.i.). The Strichen strain was slightly more virulent, possibly as a result of its having been passaged fewer times in tissue culture. In contrast, the Oxford strain produced a mild clinical response with minimal pathological lesions. Virus was recovered from nasal swabs for a longer-period from the calves infected with the Strichen strain (up to 13 days p.i.) and Colorado strain (up to 12 days p.i.) than from the animals infected with the Oxford strain (up to 10 days p.i.). These findings support the suggestion that the recent epidemic of severe IBR in Britain had resulted from the importation of a "new" strain of virus.

Experimental infection of cattle of different ages with infectious bovine rhinotracheitis virus (Strichen strain).

The clinical signs and pathological lesions which developed in various ages of cattle experimentally infected intranasally with the "Strichen" strain of IBR virus were similar to, but generally milder than, those of the field disease. The clinical signs were most severe 4 days after infection and had almost wholly regressed after 12 days. Serum neutralizing antibodies were detected in every animal. Virus was isolated from nasal and ocular swabs for up to 13 days and 10 days, respectively, after infection. The clinical signs and the pathological lesions were more severe in the younger animals.

Reactivation and shedding of bovine herpesvirus 1 following Dictyocaulus viviparus infection.

Three groups of 4 bullocks which had recovered from infectious bovine rhinotracheitis (IBR) were infected 5 months later with Dictyocaulus viviparus larvae. Bovine herpesvirus 1 was recovered from days 7 to 21 post-infection from the nasal secretions of the group given 50 larvae per kilogram and on one occasion from those given 1000 larvae per animal (less than 5 L3 per kg). Virus was not isolated from the animals given 1000 irradiated larvae. Typical clinical signs and lesions of IBR developed in the group from which the virus was isolated regularly.

Experimental production of diffuse pulmonary fibrosis and alveolitis in cattle: the effects of repeated dosage with 3, methyl indole.

Eleven Friesian steers were given 3, methyl indole (3MI) orally at dose rates ranging from 0.1 to 0.3 g/kg. Three of these (group B) received a single oral dose of 0.2 g/kg and subsequently developed respiratory distress. Their plasma 3MI concentrations six hours after dosing were between 2.25 and 7.23 micrograms/ml. The steer with the highest six-hour plasma value died at this stage and the dominant pathological feature was severe pulmonary oedema. The other two steers survived until they were slaughtered 96 hours after dosing; the major pathological findings in them were interstitial emphysema, hyaline membranes and alveolar epithelial hyperplasia. The other eight steers (group C) each received weekly oral doses of 0.1 g 3MI/kg for 10 weeks. One animal died after developing severe respiratory distress following its third dose. Thereafter, the others developed two separate patterns of response. Three steers (subgroup C1) became progressively more tolerant to oral 3MI, even in the face of dose rates increased to 0.2 and 0.3 g/kg during the 11th to 14th weeks of the study and also in the presence of relatively high plasma 3MI concentrations after dosing. One animal was slaughtered after its 10th dose and two after their 14th dose of 3MI; post mortem examinations revealed that their lungs were macro- and microscopically normal. The other steers (subgroup C2) all continued to react after each weekly oral dose of 3MI and their post-dosing plasma 3MI concentrations consistently remained relatively low. Latterly, each of the three steers which survived to the 14th week also exhibited persistent tachypnoea and marked hyperpnoea between dosings. On post mortem examination, in addition to the signs generally associated with acute 3MI toxicity (see above), each of the subgroup C2 steers were found to have diffuse pulmonary fibrosis and an alveolitis. While certain cattle appear to become tolerant to the effects of repeated doses of 3MI, the results of this study clearly demonstrated that, in others, such treatment eventually gives rise to diffuse pulmonary fibrosis and alveolitis.

The prevalence of serum neutralizing antibodies to infectious bovine rhinotracheitis virus in Scotland.

The prevalence of serum neutralizing antibodies to infectious bovine rhinotracheitis virus in 1152 serum samples from adult cattle in 114 dairy and beef herds in different regions of Scotland was 12%. In the Grampian region, the number of seropositive cattle in the self-contained herds was significantly less (P less than 0.01) than in the "other" herds. Holstein cattle had been introduced into five of these "other" herds, and significantly more (P less than 0.01) of the samples from these five herds were seropositive compared with the samples from the rest of the "other" herds in the same region into which recently purchased cattle had been introduced. The introduction of Holstein cattle was also a major factor in the association between the prevalence of antibodies and herd size in the Grampian region. The prevalence of serum neutralizing antibodies to infectious bovine rhinotracheitis virus was significantly greater (P less than 0.001) in this survey than in those previously undertaken in the United Kingdom.